Ziying N. Lei

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Metagenomic next-generation sequencing improves diagnosis of Talaromyces marneffei and mixed infections in HIV/AIDS patients: a retrospective study.

Metagenomic next-generation sequencing improves diagnosis of Talaromyces marneffei and mixed infections in HIV/AIDS patients: a retrospective study.

Journal: Frontiers in medicine

Published: January 30, 2026

Disseminated Mycobacterium abscessus lymphadenopathy in an anti-interferon-γ autoantibody syndrome patient treated with anti-NTM therapy combined with hemoadsorption: A case report.

Disseminated Mycobacterium abscessus lymphadenopathy in an anti-interferon-γ autoantibody syndrome patient treated with anti-NTM therapy combined with hemoadsorption: A case report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 26, 2025

Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow-up of long-term survival.

Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow-up of long-term survival.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: November 08, 2024

NIR-responsive CN-Pt-GEM hydrogel induces necroptosis and immunotherapeutic responses prevent postoperative recurrence and wound infection in lung carcinoma.

NIR-responsive CN-Pt-GEM hydrogel induces necroptosis and immunotherapeutic responses prevent postoperative recurrence and wound infection in lung carcinoma.

Journal: Journal of nanobiotechnology

Published: March 28, 2024

Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China.

Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China.

Journal: Liver research (Beijing, China)

Published: March 24, 2024

Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level.

Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level.

Journal: Heliyon

Published: February 06, 2024

Association of vitamin D with functional cure in chronic hepatitis B: Insights from a retrospective cohort study and an intervention study.

Association of vitamin D with functional cure in chronic hepatitis B: Insights from a retrospective cohort study and an intervention study.

Journal: Clinical nutrition ESPEN

Published: December 10, 2023

Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon.

Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon.

Journal: Frontiers in immunology

Published: November 21, 2022

Colonization with Carbapenem-Resistant Enterobacteriaceae Contributes to Unfavorable Outcomes in End-Stage Liver Disease Patients.

Colonization with Carbapenem-Resistant Enterobacteriaceae Contributes to Unfavorable Outcomes in End-Stage Liver Disease Patients.

Journal: Antibiotics (Basel, Switzerland)

Published: October 05, 2022

Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells.

Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells.

Journal: Cancer biology & medicine

Published: May 23, 2022

Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial.

Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial.

Journal: Trials

Published: April 13, 2022

Reduction in Intrahepatic cccDNA and Integration of HBV in Chronic Hepatitis B Patients with a Functional Cure.

Reduction in Intrahepatic cccDNA and Integration of HBV in Chronic Hepatitis B Patients with a Functional Cure.

Journal: Journal of clinical and translational hepatology

Published: April 12, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026